A Novel Mutation in NKX2-1 Shows Dominant-Negative Effects only in the Presence of PAX8

Hiroyuki Shinohara, Masaki Takagi, Kimiko Ito, Eri Shimizu, Ryuji Fukuzawa, Tomonobu Hasegawa

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

To date, >100 mutations in NKX2-1 have been described. Most NKX2-1 mutations are assumed to result in brain-lung-thyroid syndrome through haploinsufficiency, and only five NKX2-1 mutations with dominant-negative effects have been reported so far. In this case report, an additional patient with brain-lung-thyroid syndrome is reported, carrying a novel heterozygous mutation, c.533G>C (p.R178P), in the homeobox of NKX2-1. This mutation has been proven to be a dominant-negative mutation by an in vitro functional assay. Of note, the dominant-negative effect of R178P-NKX2-1 was shown only in the presence of PAX8.

Original languageEnglish
Pages (from-to)1071-1073
Number of pages3
JournalThyroid
Volume28
Issue number8
DOIs
Publication statusPublished - 2018 Aug 1

Fingerprint

Mutation
Haploinsufficiency
Homeobox Genes
Choreoathetosis, Hypothyroidism, And Neonatal Respiratory Distress

Keywords

  • brain-lung-thyroid syndrome
  • dominant-negative effect
  • NKX2-1
  • PAX8

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

A Novel Mutation in NKX2-1 Shows Dominant-Negative Effects only in the Presence of PAX8. / Shinohara, Hiroyuki; Takagi, Masaki; Ito, Kimiko; Shimizu, Eri; Fukuzawa, Ryuji; Hasegawa, Tomonobu.

In: Thyroid, Vol. 28, No. 8, 01.08.2018, p. 1071-1073.

Research output: Contribution to journalArticle

Shinohara, H, Takagi, M, Ito, K, Shimizu, E, Fukuzawa, R & Hasegawa, T 2018, 'A Novel Mutation in NKX2-1 Shows Dominant-Negative Effects only in the Presence of PAX8', Thyroid, vol. 28, no. 8, pp. 1071-1073. https://doi.org/10.1089/thy.2017.0481
Shinohara, Hiroyuki ; Takagi, Masaki ; Ito, Kimiko ; Shimizu, Eri ; Fukuzawa, Ryuji ; Hasegawa, Tomonobu. / A Novel Mutation in NKX2-1 Shows Dominant-Negative Effects only in the Presence of PAX8. In: Thyroid. 2018 ; Vol. 28, No. 8. pp. 1071-1073.
@article{0d37497c976846fb956174e058715203,
title = "A Novel Mutation in NKX2-1 Shows Dominant-Negative Effects only in the Presence of PAX8",
abstract = "To date, >100 mutations in NKX2-1 have been described. Most NKX2-1 mutations are assumed to result in brain-lung-thyroid syndrome through haploinsufficiency, and only five NKX2-1 mutations with dominant-negative effects have been reported so far. In this case report, an additional patient with brain-lung-thyroid syndrome is reported, carrying a novel heterozygous mutation, c.533G>C (p.R178P), in the homeobox of NKX2-1. This mutation has been proven to be a dominant-negative mutation by an in vitro functional assay. Of note, the dominant-negative effect of R178P-NKX2-1 was shown only in the presence of PAX8.",
keywords = "brain-lung-thyroid syndrome, dominant-negative effect, NKX2-1, PAX8",
author = "Hiroyuki Shinohara and Masaki Takagi and Kimiko Ito and Eri Shimizu and Ryuji Fukuzawa and Tomonobu Hasegawa",
year = "2018",
month = "8",
day = "1",
doi = "10.1089/thy.2017.0481",
language = "English",
volume = "28",
pages = "1071--1073",
journal = "Thyroid",
issn = "1050-7256",
publisher = "Mary Ann Liebert Inc.",
number = "8",

}

TY - JOUR

T1 - A Novel Mutation in NKX2-1 Shows Dominant-Negative Effects only in the Presence of PAX8

AU - Shinohara, Hiroyuki

AU - Takagi, Masaki

AU - Ito, Kimiko

AU - Shimizu, Eri

AU - Fukuzawa, Ryuji

AU - Hasegawa, Tomonobu

PY - 2018/8/1

Y1 - 2018/8/1

N2 - To date, >100 mutations in NKX2-1 have been described. Most NKX2-1 mutations are assumed to result in brain-lung-thyroid syndrome through haploinsufficiency, and only five NKX2-1 mutations with dominant-negative effects have been reported so far. In this case report, an additional patient with brain-lung-thyroid syndrome is reported, carrying a novel heterozygous mutation, c.533G>C (p.R178P), in the homeobox of NKX2-1. This mutation has been proven to be a dominant-negative mutation by an in vitro functional assay. Of note, the dominant-negative effect of R178P-NKX2-1 was shown only in the presence of PAX8.

AB - To date, >100 mutations in NKX2-1 have been described. Most NKX2-1 mutations are assumed to result in brain-lung-thyroid syndrome through haploinsufficiency, and only five NKX2-1 mutations with dominant-negative effects have been reported so far. In this case report, an additional patient with brain-lung-thyroid syndrome is reported, carrying a novel heterozygous mutation, c.533G>C (p.R178P), in the homeobox of NKX2-1. This mutation has been proven to be a dominant-negative mutation by an in vitro functional assay. Of note, the dominant-negative effect of R178P-NKX2-1 was shown only in the presence of PAX8.

KW - brain-lung-thyroid syndrome

KW - dominant-negative effect

KW - NKX2-1

KW - PAX8

UR - http://www.scopus.com/inward/record.url?scp=85051530282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051530282&partnerID=8YFLogxK

U2 - 10.1089/thy.2017.0481

DO - 10.1089/thy.2017.0481

M3 - Article

VL - 28

SP - 1071

EP - 1073

JO - Thyroid

JF - Thyroid

SN - 1050-7256

IS - 8

ER -